Delivery Order HHSN272201300015I-75N93018F00017

Award Date 6/19/18
Potential Completion Date 7/11/19
Potential Value $5.8M
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
9
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $148,458.06 delivery order to Baylor College of Medicine to transfer active work from an existing contract, HHSN272200800002C, to the Vaccine and Treatment Evaluation Units (VTEU) indefinite delivery, indefinite quantity (IDIQ) contract, HHSN27220130015I. This order is not set aside. As a prime contractor, Baylor College of Medicine, a private non-profit...
This is a delivery order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Baylor College of Medicine, a private non-profit university in Houston, Texas. The $305,327 award is under the Vaccine and Treatment Evaluation Units (VTEU) indefinite delivery contract, which supports biomedical research and clinical trials related to vaccine and treatment development. The award has a completion date of July 11, 2023 and a potential total value of...
This is a delivery order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Baylor College of Medicine, a private university and non-profit organization located in Houston, Texas. The $892,745.31 delivery order was issued under the Vaccine and Treatment Evaluation Units (VTEU) indefinite delivery, indefinite quantity (IDIQ) contract. The work involves population pharmacokinetic analyses in support of VTEU protocol development and...
This is a federal contract award to Baylor College of Medicine by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health within the U.S. Department of Health and Human Services. The $315,229.34 contract is for overall administration, clinical operations support, and concept and protocol development, implementation, and assays related to the Vaccine and Treatment Evaluation Units (VTEU) program. This is a firm fixed-price delivery order...
This $1,381,913.39 delivery order was awarded against the Vaccine and Treatment Evaluation Units (VTEU) master IDIQ contract by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. Baylor College of Medicine will provide services in support of the Vaccine Treatment Evaluation Units program in Houston, Texas under a cost-no-fee arrangement. Specifically, the contractor will conduct biodosimetry activities for $47,235 over...
Baylor College of Medicine is providing Vaccine and Treatment Evaluation Unit (VTEU) services to the National Institutes of Health National Institute of Allergy and Infectious Diseases under a $1.692 million delivery order against the Vaccine and Treatment Evaluation Units (VTEU) indefinite delivery contract. The delivery order was awarded on July 12, 2017 with a completion date of May 3, 2022. No set-aside designation was used. As the prime contractor, Baylor College of Medicine will leverage...
This federal contract award is for a $3,900,915 delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Baylor College of Medicine, a private university and non-profit organization located in Houston, Texas. The contract is part of NIAID's Vaccine and Treatment Evaluation Units (VTEU) program, which supports clinical trials for influenza and other infectious disease vaccines and treatments. The contract tasks Baylor College of Medicine with conducting a...
Baylor College of Medicine was awarded a $38,777.16 delivery order against the Vaccine and Treatment Evaluation Units (VTEU) indefinite delivery contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. As the prime contractor, Baylor College of Medicine will provide services in support of the Trans-Omics for Precision Medicine initiative through December 2020. The originating VTEU solicitation sought providers capable of performing complex genomic...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Baylor College of Medicine. The contract is for protocol development, implementation, and research laboratory analysis relative to Protocol 14-0100, with a period of performance through September 16, 2022 and a ceiling value of $2,094,753.20. The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program,...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Baylor College of Medicine, a private non-profit academic medical institution located in Houston, Texas. The $4,592,215.69 delivery order contract is part of NIAID's larger "Animal Models of Infectious Diseases 2010-2017" indefinite delivery/indefinite quantity (IDIQ) contract vehicle, which supports...

The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $5,775,132.72 delivery order to Baylor College of Medicine, a private non-profit university, to provide overall administration, clinical operations support, and concept and protocol development, implementation and assays for the Vaccine and Treatment Evaluation Units (VTEU) program. This award is under the parent VTEU indefinite delivery, indefinite quantity (IDIQ) contract, which supports biomedical research and services related to vaccines and treatments. The work will be performed in Houston, Texas, and the award has no set-aside designation.

Generated 3/21/24, 5:41 PM